These findings align with the lower prevalence of risk-associated polymorphisms in total responders, specifically in genes linked to obesity (FTO), liver injury (PNPLA3), and cardiometabolic risk (TRIB1AL), as shown in Supplementary Figure S5. The gene discussed is TRIB1AL; the disease is obesity due to melanocortin 4 receptor deficiency.